DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
It’s Black History Month, when the nation commemorates the many achievements and contributions of African Americans.
It’s also a time to reflect on certain health issues with significant mortality and morbidity that disproportionately afflict African Americans.
Sickle cell disease (SCD) is one such health problem. SCD is a group of congenital red blood cell disorders, named sickle cell for the crescent shape of red blood cells. SCD alters the structure of hemoglobin, the molecule in red blood cells that delivers oxygen to organs and tissue throughout the body. The most common SCD disorder type is sickle cell anemia.
SCD affects millions of people worldwide. In the U.S., approximately 100,000 individuals are living with the congenital disease. The disease predominantly impacts people of sub-Saharan African descent.
SCD causes significant morbidity, including severe pain, anemia, organ damage, and infections. The disease also leads to premature mortality.
news & eventsInvestigational Oral Inhibitor IMR-687 Shows Promising Results in Ongoing Phase 2 Clinical TrialImara’s investigational oral inhibitor...
news & events
news & eventsBCL11A-based gene therapy for sickle cell disease passes key preclinical testA precision-engineered gene therapy viru...
news & eventsCTX001 Earns FDA’s Fast Track Status for Treating Sickle Cell DiseaseThe U.S. Food and Drug Administration (F...
education & researchA Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive EventsBACKGROUND: Sickle cell anemia is an inh...
news & eventsCTX001 Continues to Show Promise in Severe SCDA single dose of CTX001, an experimental...
education & researchImproved clinical outcomes in adults with sickle cell disease and diabetes treated with metforminComplications of sickle cell disease (SC...
send a message
Don’t forget to join the oneSCDvoice community!
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.